Kezar Life Sciences said it voluntarily suspended enrollment and dosing in a clinical trial of a treatment for an autoimmune kidney disease after four patients died.
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing a novel small molecule to treat unmet needs in immune-mediated diseases, today announced the voluntary ...
British Sri Lankan rapper and producer M.I.A. captivated the 2024 Portola Music Festival crowd in San Francisco during the final night of the two-day outdoor event, marking her return to the Bay Area ...
Some results have been hidden because they may be inaccessible to you